|
09 Jan 2007 |
The Medicines Company's Cleviprex(TM) (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives
|
|
09 Jan 2007 |
Anesiva Announces Clinical Plan for Pivotal Testing of 4975, Long-Acting Pain Candidate
|
|
09 Jan 2007 |
deCODE Advancing Lead Product Development Programs
|
|
09 Jan 2007 |
Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 Trial of Its Novel Antifolate PDX in Patients With Peripheral T-cell Lymphoma
|
|
09 Jan 2007 |
Quatrx Pharmaceuticals Reports Positive Results From A Phase 2 Trial Of Fispemifene
|
|
09 Jan 2007 |
Xanthus Receives Orphan Drug Designation of Xanafide for the Treatment Of AML
|
|
09 Jan 2007 |
ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate
|
|
09 Jan 2007 |
Targacept Initiates Phase I Clinical Trial of TC-2216
|
|
09 Jan 2007 |
TaiGen Initiates Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
|
|
09 Jan 2007 |
Rigel Announces Initiation of Phase II Study Evaluating R788 in Immune Thrombocytopenic Purpura (ITP)
|
|
09 Jan 2007 |
Horizon Therapeutics Announces Special Protocol Assessment With Fda For Phase 3 Trial Program
|
|
08 Jan 2007 |
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for INNO-406 for the Treatment of Chronic Myelogenous Leukemia
|
|
06 Jan 2007 |
OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
|
|
06 Jan 2007 |
Hypnion, Inc. Announces Positive And Robust Phase II Results For Novel Sleep Drug - HY10275
|
|
06 Jan 2007 |
TargeGen Selects Jak2 Inhibitor Lead (TG101348) for Clinical Development as a Potential Therapy for Myeloproliferative Diseases Including Polycythemia Vera (PV)
|
|
05 Jan 2007 |
Medivir Files Clinical Trial Application To Start Phase I With MIV-701
|
|
05 Jan 2007 |
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
|
|
05 Jan 2007 |
Pharmacopeia Enters into a Research and License Agreement with Wyeth to Develop Novel JAK3 Inhibitors for the Treatment of Immunological and Inflammatory Diseases
|
|
05 Jan 2007 |
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
|
|
05 Jan 2007 |
Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
|
|
05 Jan 2007 |
Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
|
|
05 Jan 2007 |
AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
|
|
05 Jan 2007 |
Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005
|
|
05 Jan 2007 |
BiPar Sciences Begins Enrollment in Phase 1b Study of BSI-201
|
|
05 Jan 2007 |
Neosil Announces Positive Phase 2 Data for NEOSH101, an Investigational Treatment for Androgenetic Alopecia
|
